Hepatocellular Carcinoma Clinical Trials in Mulhouse
2 recruitingMulhouse, France
Showing 1–2 of 2 trials
Recruiting
Phase 2
Evaluation of the Interest to Combine a CD4 Th1-inducer Cancer Vaccine Derived From Telomerase and Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Hepatocellular Carcinoma
Centre Hospitalier Universitaire de Besancon105 enrolled14 locationsNCT05528952
Recruiting
Not Applicable
Identification of Innovative Biomarkers to Predict Outcomes in Hepatocellular Carcinoma Treated With Tremelimumab and Durvalumab
Hepatocellular Carcinoma
Centre Hospitalier Universitaire de Besancon120 enrolled10 locationsNCT06796114